This inventor holds 4 USPTO granted patents and 4 published patent applications. Top assignee: Syros Pharmaceuticals, Inc.. Active years: 2020-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2023
Title: Boubacar Sow: Innovator in Cancer Treatment
Introduction
Boubacar Sow is a notable inventor based in Saint-Laurent, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the modulation of Myc activity, which is crucial for treating various proliferative diseases.
Latest Patents
Boubacar Sow holds 4 patents that focus on novel compounds for the modulation of Myc activity. His latest patents include innovative compounds of Formulas (I) and (II), along with their pharmaceutically acceptable salts, solvates, hydrates, tautomers, stereoisomers, and isotopically labeled derivatives. These inventions provide methods and kits for treating or preventing proliferative diseases such as various cancers, benign neoplasms, inflammatory diseases, and autoimmune diseases.
Career Highlights
Boubacar Sow is currently employed at Syros Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His work is pivotal in the ongoing fight against cancer and other serious health conditions.
Collaborations
He collaborates with esteemed colleagues such as Jason J Marineau and Kevin Sprott, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Boubacar Sow's contributions to the field of pharmaceuticals and his innovative patents position him as a key figure in the development of treatments for serious diseases. His work continues to inspire advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile